跳至主要内容
临床试验/NCT01226667
NCT01226667已完成4 期

Fixed Versus Flexible Dosing of Pregabalin in Patients With Fibromyalgia

Osteoporosis Medical Center, Beverly Hills, CA5 个研究点 分布在 1 个国家目标入组 174 人开始时间: 2010年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
174
试验地点
5
主要终点
Pain score evaluation by NRS

研究概览

简要总结

A 9-week randomized double-blind, multi-center study of 172 patients, who after 1 week baseline evaluation are randomized to either fixed dose pregabalin starting at 75 mg BID for one week and increased to 150 mg BID for 7 weeks or flexibly dosed pregabalin given BID (75-300 mg/d) increased gradually over 4 weeks then maintained at that same dosing for 4 weeks.It is proposed that use of flexible dosing combined with nightly dosing would have similar pain relief to fixed dosing, would improve adherence, would have less side effects and would be more likely to improve sleep.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • diagnosis of fibromyalgia by ACR criteria
  • ambulatory patients
  • complete of 5 pain diaries during 1 week evaluation
  • other inclusion criteria may apply

排除标准

  • pregnant or of childbearing potential not using contraceptives
  • use of pregabalin in the past
  • concomitant use of opioids or gabapentin
  • estimated creatinine clearance less than 60
  • other criteria may apply

研究组 & 干预措施

Flexible Dose

Active Comparator

flexibly dosed pregabalin given BID (75-300 mg/d) increased gradually over 4 weeks then maintained at that same dosing for 4 weeks

干预措施: Pregabalin (Drug)

Fixed Dosing

Active Comparator

75 mg BID for one week and increased to 150 mg BID for 7 weeks

干预措施: Pregabalin (Drug)

结局指标

主要结局

Pain score evaluation by NRS

时间窗: 8 weeks

Least square mean change in Fibromyalgia pain at 8weeks compared to baseline utilizing an 11 point numerical rating scale daily pain diary (0 = no pain to 10 =worst possible pain) performed at daily awakening.

次要结局

  • Patient Global Impression of Change(At weeks 4 and 8)
  • Discontinuation rate(9 weeks)
  • Improvements in Wolfe Symptom Severity Score(9 weeks)

研究者

发起方
Osteoporosis Medical Center, Beverly Hills, CA
申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

Fixed Versus Flexible Dosing of Pregabalin in... | 临床试验